Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Vascular Biogenics Ltd. (VBLT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/10/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/10/2023 8-K Other Events  Interactive Data
10/04/2023 425 Form 425 - Prospectuses and communications, business combinations:
10/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Assets"
10/02/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/23/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 425 Form 425 - Prospectuses and communications, business combinations:
08/14/2023 8-K Quarterly results
Docs: "VBL Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update"
07/26/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
06/30/2023 S-4/A Form S-4/A - Registration of securities, business combinations: [Amend]
06/09/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/17/2023 425 Form 425 - Prospectuses and communications, business combinations:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 S-4 Form S-4 - Registration of securities, business combinations:
04/18/2023 425 Form 425 - Prospectuses and communications, business combinations:
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/14/2023 425 Form 425 - Prospectuses and communications, business combinations:
03/14/2023 425 Form 425 - Prospectuses and communications, business combinations:
03/14/2023 8-K Quarterly results
Docs: "VBL Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update"
03/14/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 425 Form 425 - Prospectuses and communications, business combinations:
03/09/2023 8-K Completion of Acquisition or Disposition of Assets  Interactive Data
03/01/2023 8-K Quarterly results
02/23/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/23/2023 425 Form 425 - Prospectuses and communications, business combinations:
02/23/2023 8-K Investor presentation
Docs: "AGREEMENT AND PLAN OF MERGER among: VASCULAR BIOGENICS LTD; VIBRANT MERGER SUB, INC.; and NOTABLE LABS, INC. Dated as of February 22, 2023",
"VBL Therapeutics and Notable Labs Announce Definitive Merger Agreement"
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
01/03/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy